InvestorsHub Logo
Followers 46
Posts 3111
Boards Moderated 0
Alias Born 12/30/2013

Re: None

Wednesday, 09/16/2015 1:43:00 PM

Wednesday, September 16, 2015 1:43:00 PM

Post# of 3443
"Additionally, Idera announced that pre-clinical data relating to the combination of intratumoral IMO-2125 and an anti-PD-1 mAb in a murine colon carcinoma model will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston from November 5-9th."

Great news today!